Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF- α inhibition - Cho,M.K.; Jang,Y.P.; Kim,Y.C.; Kim,S.G. (Int Immunopharmacol, 2004)